Cargando…
Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study
Severe acute respiratory coronavirus-2 (SARS-CoV-2) still presents a public threat and puts extra strain on healthcare facilities. Without an effective antiviral drug, all available treatment options are considered supportive. Tocilizumab as a treatment option has to date shown variable results. In...
Autores principales: | Al-Qaaneh, Ayman M., Al-Ghamdi, Fuad H., AbdulAzeez, Sayed, Borgio, J. Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953525/ https://www.ncbi.nlm.nih.gov/pubmed/35335998 http://dx.doi.org/10.3390/pharmaceutics14030624 |
Ejemplares similares
-
In-Silico Computing of the Most Deleterious nsSNPs in HBA1 Gene
por: AbdulAzeez, Sayed, et al.
Publicado: (2016) -
A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia
por: Alaithan, Mousa A., et al.
Publicado: (2018) -
Genomic Insights into Virulence Factors and Multi-Drug Resistance in Clostridium perfringens IRMC2505A
por: AlJindan, Reem, et al.
Publicado: (2023) -
Environmental and Genetic Factors in Autism Spectrum Disorders: Special Emphasis on Data from Arabian Studies
por: Almandil, Noor B., et al.
Publicado: (2019) -
Drug Resistance-Associated Mutations in ERG11 of Multidrug-Resistant Candida auris in a Tertiary Care Hospital of Eastern Saudi Arabia
por: AlJindan, Reem, et al.
Publicado: (2020)